During the past decade, Beijing Anzhen Hospital conducted 193 clinical trials. In the 10-year time frame, 193 clinical trials started and 18 clinical trials were completed, i.e. on average, 9.3% percent of trials that started reached the finish line to date. In the past 5 years, 95 clinical trials started and 16 clinical trials were completed. i.e. 16.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Beijing Anzhen Hospital" #1 sponsor was "Beijing Anzhen Hospital" with 62 trials, followed by "Beijing Institute of Heart, Lung and Blood Vessel Diseases" with 17 trials sponsored, "Actelion" with 13 trials sponsored, "Boehringer Ingelheim" with 5 trials sponsored and "Nanjing Medical University" with 5 trials sponsored. Other sponsors include 115 different institutions and companies that sponsored additional 93 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Beijing Anzhen Hospital" #1 collaborator was "Beijing Anzhen Hospital" with 20 trials as a collaborator, "Guangdong Provincial People's Hospital" with 5 trials as a collaborator, "Beijing Chao Yang Hospital" with 4 trials as a collaborator, "Beijing Luhe Hospital" with 4 trials as a collaborator and "Chinese PLA General Hospital" with 4 trials as a collaborator. Other collaborators include 218 different institutions and companies that were collaborators in the rest 178 trials.

According to Clinical.Site data, the most researched conditions in "Beijing Anzhen Hospital" are "Coronary Artery Disease" (27 trials), "Atrial Fibrillation" (11 trials), "Pulmonary Arterial Hypertension" (10 trials), "Acute Coronary Syndrome" (8 trials) and "Heart Failure" (7 trials). Many other conditions were trialed in "Beijing Anzhen Hospital" in a lesser frequency.

Most popular intervention types in "Beijing Anzhen Hospital" are "Drug" (108 trials), "Device" (49 trials), "Procedure" (23 trials), "Other" (20 trials) and "Behavioral" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "placebo" (5 trials), "Macitentan 10 mg" (4 trials), "No intervention" (4 trials) and "5% Glucose Injection" (2 trials). Other intervention names were less common.

The vast majority of trials in "Beijing Anzhen Hospital" are 217 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 84 active trials in "Beijing Anzhen Hospital". 6 are not yet recruiting, 54 are recruiting, 21 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 55 completed trials in Beijing Anzhen Hospital, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Beijing Anzhen Hospital, 5 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 43 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 25 trials, and there were also 72 trials that are defined as “Not Applicable".